Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R de Groot

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 21, 2013
Epicardial mapping and ablation of arrhythmias: is magnetic navigation the answer we have been waiting for?J R de Groot, T Deneke
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 8, 2022
Arterial stiffness and atrial fibrillation recurrence: another risk marker or a call for better management of concomitant disease?J R de Groot, D Linz
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 14, 2018
Do we understand the rationale behind driving restrictions in patients with an implantable cardioverter defibrillator?S W E Baalman, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 12, 2020
Therapeutic options for patients with advanced atrial fibrillation: from lifestyle and medication to catheter and surgical ablationL Boersma, M Rienstra, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 19, 2021
Medications that interact with direct-acting oral anticoagulant exposureT A C de Vries, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 21, 2019
Experience with non-vitamin K antagonists in the Netherlands: stories from both sides of the deskT A C de Vries, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 6, 2015
Myocardial infarction, atrial fibrillation and mortality: timing is everythingN W E van den Berg, J R de Groot
Cardiovascular Research|May 30, 2001
Defining heart failureR Coronel, J R de Groot, J J van Lieshout
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 25, 2013
Internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients: the juice is not worth the squeezeW R Berger, R E Knops, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 11, 2013
Who benefits from implantable cardioverter defibrillator therapy, and who pays the price?L R A Olde Nordkamp, R E Knops, J R de Groot
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 21, 2013
Epicardial mapping and ablation of arrhythmias: is magnetic navigation the answer we have been waiting for?J R de Groot, T Deneke
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 8, 2022
Arterial stiffness and atrial fibrillation recurrence: another risk marker or a call for better management of concomitant disease?J R de Groot, D Linz
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 14, 2018
Do we understand the rationale behind driving restrictions in patients with an implantable cardioverter defibrillator?S W E Baalman, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 12, 2020
Therapeutic options for patients with advanced atrial fibrillation: from lifestyle and medication to catheter and surgical ablationL Boersma, M Rienstra, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 19, 2021
Medications that interact with direct-acting oral anticoagulant exposureT A C de Vries, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 21, 2019
Experience with non-vitamin K antagonists in the Netherlands: stories from both sides of the deskT A C de Vries, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 6, 2015
Myocardial infarction, atrial fibrillation and mortality: timing is everythingN W E van den Berg, J R de Groot
Cardiovascular Research|May 30, 2001
Defining heart failureR Coronel, J R de Groot, J J van Lieshout
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 25, 2013
Internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients: the juice is not worth the squeezeW R Berger, R E Knops, J R de Groot
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 11, 2013
Who benefits from implantable cardioverter defibrillator therapy, and who pays the price?L R A Olde Nordkamp, R E Knops, J R de Groot
Pageof 6